Icon revises earnings potential after strong Q2 results

Icon, the drug development solutions provider which employs more than 1,000 people in Ireland, yesterday revised upwards its earnings and revenue guidance for the year on the back of strong second quarter results.

The Dublin-headquartered firm reported revenue of $389m (€351.8m), up almost 3.5% on the same period last year.

Income from operations increased by 41% to $68.1m or 17.5% of revenue compared to $48.3 million or 12.8% for the same quarter last year.